On Friday, Cathie Wooden-led Ark Make investments made vital trades involving Beam Therapeutics Inc. BEAM, Nu Holdings Ltd. NU, MercadoLibre Inc. MELI, and Adaptive Biotechnologies Corp. ADPT.
The BEAM Commerce
Ark Make investments, via its ARK Genomic Revolution ETF ARKG and ARK Innovation ETF ARKK, purchased a complete of 24,640 shares of Beam Therapeutics.
This comes after the agency’s earlier acquisition of Beam Therapeutics shares only a week prior. The worth of this commerce, calculated from the most recent closing worth is almost $750,000.
The NU Commerce
Ark Make investments, via its ARK Fintech Innovation ETF ARKF, purchased 162,143 shares of Nu Holdings Ltd. This marks a major funding within the fintech firm, reflecting Ark’s strategic positioning within the dynamic tech sector.
The worth of this commerce, calculated from the most recent closing worth is over $1.75 million.
The MELI and ADPT Trades
On the identical day, Ark Make investments additionally bought shares of MercadoLibre Inc and Adaptive Biotechnologies Corp. Via its ARK Fintech Innovation ETF, Ark bought 347 shares of MercadoLibre.
In the meantime, via its ARK Genomic Revolution ETF, Ark offloaded 8,129 shares of Adaptive Biotechnologies.
Learn Subsequent:
Disclaimer: This content material was partially produced with the assistance of AI instruments and was reviewed and printed by Benzinga editors.
Picture courtesy: Ark Make investments
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
